2024 Ethics Safety 
European Pharmaceutical Review
APRIL 2, 2024
At Roche, we see it as our ethical and environmental responsibility to support the use of alternative methods that prioritise animal welfare while ensuring the safety of our patients and the quality of our products. in the monographs for Water for Injection (0169) and Purified Water (0008) on 1 April 2024. on 1 January 2024.
European Pharmaceutical Review
DECEMBER 19, 2024
Yet, AI remains the top area for investment over the next two years, according to 62 percent of respondents in Pistoias 2024 Lab of the Future report. For example, our 2024 paper on good machine learning practices, 7 or our FAIR Toolkit. Lab of the Future Survey 2024. Internet] GlobalData. Available from: [link] 2.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
NOVEMBER 21, 2024
This will lead to more structured, evidence-based treatments for these conditions, addressing the critical questions of safety and long-term efficacy. For now, the regulatory landscape remains focused on ensuring the safety and efficacy of the drug itself. Trials must be designed meticulously, with strong safety protocols in place.
Pharmaceutical Representative Training
JUNE 22, 2024
Ethical Conduct: In pharma sales, ethical conduct and behavior is crucial. Ethical conduct helps maintain the company’s integrity and foster trust with HCPs and patients. The pharmaceutical industry is one of the most heavily regulated sectors due to the direct impact of its products on public health and safety.
Nixon Gwilt Law
APRIL 22, 2024
The rule aims to regulate and enhance the transparency, effectiveness, and safety of predictive DSIs used in healthcare settings, ensuring that these technologies are developed and managed responsibly. This oversight is crucial in minimizing errors that could compromise patient safety.
Nixon Gwilt Law
APRIL 22, 2024
The rule aims to regulate and enhance the transparency, effectiveness, and safety of predictive DSIs used in healthcare settings, ensuring that these technologies are developed and managed responsibly. This oversight is crucial in minimizing errors that could compromise patient safety.
PM360
JUNE 24, 2024
Regulatory Compliance and Ethical Considerations It may sound like an obvious statement, but to engage patient audiences as a commercial entity, someone needs to keep a regulatory eye on the program. It will also help patients set appropriate expectations around safety, efficacy, and their potential eligibility for your investigational drug.
Expert insights. Personalized for you.
98 
Let's personalize your content